| Literature DB >> 20739833 |
Eun-Jung Lim1, Dae-Weon Park, Jin-Gu Lee, Chu-Hee Lee, Yoe-Sik Bae, Young-Chul Hwang, Jae-Weon Jeong, Byung-Rho Chin, Suk-Hwan Baek.
Abstract
Synthetic oligodeoxynucleotides (ODN) with a CpG-motif are recognized by Toll-like receptor 9 (TLR9) and pleiotropic immune responses are elicited. Stimulation of macrophages with TLR9 agonist prevented apoptosis induced by serum deprivation through increased expression of FLICE-like inhibitory protein (FLIP). CpG ODN-mediated anti-apoptosis depended on the TLR9-Akt-FoxO3a signaling pathway. Inhibition of TLR9 by small interfering (si) RNA or an inhibitor suppressed CpG ODN-mediated anti-apoptosis. Analysis of signaling pathways revealed that the anti-apoptotic effect of CpG ODN required phosphorylation of FoxO3a and its translocation from the nucleus to the cytosol. Overexpression of FoxO3a increased apoptosis induced by serum deprivation and CpG ODN blocked these effects through FLIP expression. In contrast, siRNA knock-down of FoxO3a decreased apoptosis by serum deprivation. In addition, Akt activation was involved in CpG ODN-induced phosphorylation of FoxO3a, expression of FLIP, and anti-apoptosis. Taken together, these results demonstrate the involvement of Akt-FoxO3a in TLR9-mediated anti-apoptosis and indicate that FoxO3a is a distinct regulator for FLIP expression.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20739833 PMCID: PMC2966745 DOI: 10.3858/emm.2010.42.10.070
Source DB: PubMed Journal: Exp Mol Med ISSN: 1226-3613 Impact factor: 8.718